Fundz

Maxwell Biosciences raised $20M in a Financing Round to expand commercialization of its immune-inspired small molecules, Claromers, for various industries.

PRIVATEAug 07, 2025

Amount Raised

$20 Million

Round Type

Funding Round

West Lake HillsBiotechnology

Description

Maxwell Biosciences closed a $20M financing round to support its commercial efforts with immune-inspired small molecules called Claromers. The company aims to enter multiple industries, including cosmetics and cleaning products. The details of the backers are not disclosed. Maxwell is focused on delivering nontoxic antiseptic solutions while collaborating with governments and commercial partners.

Quick answer

Maxwell Biosciences raised $20 Million in a Funding Round round, dated August 7, 2025. Maxwell Biosciences is based in West Lake Hills, Texas, United States.

How much did Maxwell Biosciences raise?
Maxwell Biosciences raised $20 Million in a Funding Round round on August 7, 2025.
What does Maxwell Biosciences do?
Maxwell Biosciences is a preclinical-stage company developing next-generation anti-infectives that mimic natural human antimicrobial peptides.
Where is Maxwell Biosciences based and how big is it?
Maxwell Biosciences is based in West Lake Hills, Texas, United States. Fundz records about 24 employees.
Who are the decision-makers at Maxwell Biosciences?
Fundz holds 1 contact at Maxwell Biosciences, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Maxwell Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • FOXO Technologies raised $600K on September 19, 2025.
  • Space Cargo Unlimited raised $33M (Series A) on September 19, 2025.
  • Insignum AgTech raised $2.4M (Seed) on September 19, 2025.
  • Revive Therapeutics raised $91K (Post-IPO Equity) on September 19, 2025.
  • MoldCo raised $8M (Seed) on September 18, 2025.
  • Immuto Scientific raised $8M (Seed) on September 18, 2025.

Who to call at Maxwell Biosciences, and when

A new round usually means Maxwell Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Maxwell Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Maxwell Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Maxwell Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Maxwell Biosciences

Location

3809 Juniper Trace

West Lake Hills, Texas, United States

About

Maxwell Biosciences is a preclinical-stage company developing next-generation anti-infectives that mimic natural human antimicrobial peptides. Its patented CLAROMER™ platform targets viruses, fungi, and bacteria—including SARS-CoV-2, HSV-1, and deadly respiratory fungal infections. Supported by over $35M in global grants and validated by leading research institutions, Maxwell’s compounds show strong safety and efficacy. The company is now raising funds for advanced preclinical and human trials.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Maxwell Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJoshua M., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Maxwell Biosciences's next move

See what Strategic adds

Maxwell Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.